Great Valley Advisor Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,334
| Closed | -$208K | – | 926 |
|
2025
Q1 | $208K | Buy |
7,334
+141
| +2% | +$4K | ﹤0.01% | 825 |
|
2024
Q4 | $299K | Sell |
7,193
-55
| -0.8% | -$2.29K | 0.01% | 695 |
|
2024
Q3 | $485K | Sell |
7,248
-95
| -1% | -$6.35K | 0.01% | 568 |
|
2024
Q2 | $872K | Sell |
7,343
-631
| -8% | -$74.9K | 0.02% | 412 |
|
2024
Q1 | $849K | Buy |
7,974
+183
| +2% | +$19.5K | 0.03% | 399 |
|
2023
Q4 | $775K | Sell |
7,791
-503
| -6% | -$50K | 0.03% | 380 |
|
2023
Q3 | $857K | Sell |
8,294
-407
| -5% | -$42K | 0.04% | 342 |
|
2023
Q2 | $1.06M | Sell |
8,701
-229
| -3% | -$27.8K | 0.04% | 306 |
|
2023
Q1 | $1.37M | Buy |
8,930
+3,698
| +71% | +$568K | 0.06% | 262 |
|
2022
Q4 | $940K | Buy |
5,232
+2,786
| +114% | +$500K | 0.05% | 333 |
|
2022
Q3 | $289K | Sell |
2,446
-1,714
| -41% | -$203K | 0.02% | 542 |
|
2022
Q2 | $595K | Buy |
4,160
+1,348
| +48% | +$193K | 0.03% | 395 |
|
2022
Q1 | $490K | Buy |
2,812
+99
| +4% | +$17.3K | 0.03% | 391 |
|
2021
Q4 | $695K | Sell |
2,713
-7,998
| -75% | -$2.05M | 0.04% | 323 |
|
2021
Q3 | $4.12M | Buy |
10,711
+4,734
| +79% | +$1.82M | 0.28% | 90 |
|
2021
Q2 | $1.4M | Sell |
5,977
-403
| -6% | -$94.4K | 0.1% | 205 |
|
2021
Q1 | $835K | Sell |
6,380
-2,049
| -24% | -$268K | 0.08% | 220 |
|
2020
Q4 | $881K | Sell |
8,429
-781
| -8% | -$81.6K | 0.09% | 200 |
|
2020
Q3 | $651K | Sell |
9,210
-2,522
| -21% | -$178K | 0.08% | 204 |
|
2020
Q2 | $753K | Sell |
11,732
-645
| -5% | -$41.4K | 0.12% | 179 |
|
2020
Q1 | $370K | Buy |
+12,377
| New | +$370K | 0.1% | 216 |
|